Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
Competitive Analysis
Competitive Analysis (cont.)
| Pharmacyclics Inc. | Dr. Reddy's Laboratories Ltd. ADS | AstraZeneca PLC ADS | Astrazeneca PLC | Shire PLC ADS | GlaxoSmithKline PLC ADS | |
| Industry | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology |
| Current Share Price | 75.55 | 34.38 | 50.43 | 49.95 | 89.13 | 46.79 |
| Market Value | $5,471 mil | $5,914 mil | $62,974 mil | $62,974 mil | $16,457 mil | $114,524 mil |
| Revenues | $82 mil | $97,086 mil | $17,653 mil | $17,653 mil | $2,954 mil | $26,431 mil |
| Net Earnings | $12 mil | $13,009 mil | $3,993 mil | $3,993 mil | $470 mil | $4,744 mil |
| 5-yr Sales Growth | NA | 18.90% | 0.48% | 0.48% | 15.84% | 1.71% |
| 5-yr Earnings Growth | -23.53% | 38.99% | 7.45% | 7.45% | 85.87% | 0.78% |
| Net Profit Margin | 53.31% | 12.06% | 22.52% | 22.52% | 15.98% | 17.27% |
| Short Interest | 4.86 | 2.91 | 1.77 | NA | 1.35 | 1.61 |
| Proj. Long-Term EPS Growth (%) | 20.83% | NA | -6.01% | -5.71% | 12.92% | 5.21% |
| Forward P/E | NA | 20.32 | 9.42 | 9.42 | 13.20 | 13.18 |
| PEG | NA | 1.10 | NA | NA | 1.15 | 1.69 |
| Price/Sales | 32.03 | 2.95 | 2.34 | 2.34 | 3.62 | 2.82 |
| Price/Cash Flow | NA | NA | 21.37 | 21.37 | 15.68 | -55.83 |
| Price/Book | 28.65 | 5.98 | 2.48 | 2.48 | 4.53 | 11.27 |
| ROE | NA | 23.39% | 28.10% | 28.10% | 20.88% | 63.59% |
| ROA | 32.27% | 10.86% | 12.12% | 12.12% | 10.81% | 11.07% |
| Dividends | NA | $0.25 | $1.90 | $1.93 | $0.44 | $0.69 |
| Dividend Yield | NA | 0.72% | 7.54% | 7.72% | 0.98% | 4.95% |
| Payout Ratio | NA | 17.91% | 56.71% | 56.71% | 13.14% | 79.66% |
| Total Return (12-mos) | 162.97% | 2.32% | 14.16% | 13.52% | -7.45% | 3.93% |
| Total Return (3-yr) | 950.77% | 25.51% | 18.71% | 11.37% | 33.15% | 28.89% |
| Beta | 0.65 | 0.12 | 0.31 | 0.31 | 0.30 | 0.26 |
| % Off 52-wk High | 21.18% | 6.40% | 0.51% | 0.79% | 12.65% | 1.90% |
| % Above 52-wk Low | 208.37% | 26.03% | 26.96% | 25.35% | 11.29% | 12.26% |
| Consensus Analyst Recommendation | Overweight | Overweight | Hold | Hold | Overweight | Hold |
